MPLNET.com » News » Dr. Bevan Tandon Joins MPLN's Pathology Team Client Login | Email | Phone: 1.800.932.2943

Dr. Bevan Tandon Joins MPLN’s Pathology Team


Posted on August 18, 2015 by J Seabrook

Bevan Tandon, M.D. recently joined  Molecular Pathology Laboratory Network, having completed a clinical fellowship in molecular genetic pathology at Washington University in St. Louis School of Medicine. Dr. Tandon has subspecialty board certifications in Molecular Genetic Pathology (2015), as well as Hematopathology (2013), and his general boards are in Anatomic and Clinical Pathology (2012).  Dr. Tandon completed his training in Hematopathology at the University Pittsburgh School of Medicine where he served as a fellow and clinical instructor.  His residency training in general anatomic and clinical pathology was completed at Northwestern Memorial Hospital in Chicago, IL.  Dr. Tandon received his Medical Doctorate in 2008  from Eastern Virginia Medical School, and his undergraduate degrees were in neuroscience and philosophy, received from the University of Pittsburgh.

During the course of his training at Washington University, Dr. Tandon’s clinical activities were focused on interpretation of targeted next generation sequencing studies of malignant neoplasms and cardiomyopathies in the Genomics and Pathology Services division.  He also served in the molecular diagnostics laboratory at Barnes Jewish Hospital during this time.

Dr. Tandon's experience and expertise adds to the strengths of MPLN's Molecular Pathology group as we engage in the development of Genomic Testing. His academic interests are in hematopathology and clinical genomics.  He has several publications to his credit, including:

  • Duncavage, Tandon. 2015. Utility of Next Generation Sequencing in Diagnosis and Monitoring of AML and MDS. International Journal of Laboratory Hematology. May;37 Suppl 1:115-21
  • Tandon, Swerdlow, et al. 2015. Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell Follicle?  Leukemia Lymphoma. May 26:1-9.
  • Tandon et al.  2011. Nuclear Overexpression of Lymphoid Enhancer Binding Factor 1 Identifies CLL/SLL in Small B Cell Lymphomas. Modern Pathology Nov: 24;1433-43;
  • Tandon et al. 2010. Congenital Dyserythropoietic Anemia Type 2 Diagnosed in an Adult Patient. Journal of Hematopathology. 3:149–153.
  • Maldjian C, Tandon B, et al. 2014. Lymphatic Filariasis disseminating to the Upper Extremity. Case Reports in Radiology. 985680

Connect with Dr. Tandon on Linked In

Commenting is turned off for this post.